Follow
Raymond Schuch
Raymond Schuch
ContraFect Corporation
Verified email at contrafect.com - Homepage
Title
Cited by
Cited by
Year
A bacteriolytic agent that detects and kills Bacillus anthracis
R Schuch, D Nelson, VA Fischetti
Nature 418 (6900), 884-889, 2002
8772002
Identification of a Broadly Active Phage Lytic Enzyme with Lethal Activity against Antibiotic-Resistant Enterococcus faecalis and Enterococcus faecium
P Yoong, R Schuch, D Nelson, VA Fischetti
Journal of bacteriology 186 (14), 4808-4812, 2004
3312004
Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model
R Lood, BY Winer, AJ Pelzek, R Diez-Martinez, M Thandar, CW Euler, ...
Antimicrobial agents and chemotherapy 59 (4), 1983-1991, 2015
2672015
PlyC: a multimeric bacteriophage lysin
D Nelson, R Schuch, P Chahales, S Zhu, VA Fischetti
Proceedings of the National Academy of Sciences 103 (28), 10765-10770, 2006
2542006
Reinventing phage therapy: are the parts greater than the sum?
VA Fischetti, D Nelson, R Schuch
Nature biotechnology 24 (12), 1508-1511, 2006
2382006
Lysins: the arrival of pathogen-directed anti-infectives
M Pastagia, R Schuch, VA Fischetti, DB Huang
Journal of medical microbiology 62 (10), 1506-1516, 2013
2352013
The secret life of the anthrax agent Bacillus anthracis: bacteriophage-mediated ecological adaptations
R Schuch, VA Fischetti
PloS one 4 (8), e6532, 2009
2142009
Combination Therapy With Lysin CF-301 and Antibiotic Is Superior to Antibiotic Alone for Treating Methicillin-Resistant Staphylococcus aureus–Induced Murine …
R Schuch, HM Lee, BC Schneider, KL Sauve, C Law, BK Khan, JA Rotolo, ...
The Journal of infectious diseases 209 (9), 1469-1478, 2014
2112014
Bacteriophage lysin CF-301, a potent antistaphylococcal biofilm agent
R Schuch, BK Khan, A Raz, JA Rotolo, M Wittekind
Antimicrobial agents and chemotherapy 61 (7), 10.1128/aac. 02666-16, 2017
1522017
Detailed Genomic Analysis of the Wβ and γ Phages Infecting Bacillus anthracis: Implications for Evolution of Environmental Fitness and Antibiotic Resistance
R Schuch, VA Fischetti
Journal of bacteriology 188 (8), 3037-3051, 2006
1242006
PlyPH, a Bacteriolytic Enzyme with a Broad pH Range of Activity and Lytic Action against Bacillus anthracis
P Yoong, R Schuch, D Nelson, VA Fischetti
Journal of bacteriology 188 (7), 2711-2714, 2006
1232006
The 1.6 Å Crystal Structure of the Catalytic Domain of PlyB, a Bacteriophage Lysin Active Against Bacillus anthracis
CJ Porter, R Schuch, AJ Pelzek, AM Buckle, S McGowan, MCJ Wilce, ...
Journal of molecular biology 366 (2), 540-550, 2007
1112007
MxiE Regulates Intracellular Expression of Factors Secreted by the Shigella flexneri 2a Type III Secretion System
CD Kane, R Schuch, WA Day Jr, AT Maurelli
Journal of bacteriology 184 (16), 4409-4419, 2002
1102002
A system for identifying post‐invasion functions of invasion genes: requirements for the Mxi–Spa type III secretion pathway of Shigella flexneri in intercellular …
R Schuch, RC Sandlin, AT Maurelli
Molecular microbiology 34 (4), 675-689, 1999
1101999
MxiM and MxiJ, Base Elements of the Mxi-Spa Type III Secretion System of Shigella, Interact with and Stabilize the MxiD Secretin in the Cell Envelope
R Schuch, AT Maurelli
Journal of bacteriology 183 (24), 6991-6998, 2001
1002001
Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis
VG Fowler, AF Das, J Lipka-Diamond, R Schuch, R Pomerantz, ...
The Journal of clinical investigation 130 (7), 3750-3760, 2020
902020
Development of a high throughput assay for indirectly measuring phage growth using the OmniLogTM system
M Henry, B Biswas, L Vincent, V Mokashi, R Schuch, KA Bishop-Lilly, ...
Bacteriophage 2 (3), 159-167, 2012
822012
Characterization of a Bacillus subtilis sporulation operon that includes genes for an RNA polymerase sigma factor and for a putative DD-carboxypeptidase
JJ Wu, R Schuch, PJ Piggot
Journal of bacteriology 174 (15), 4885-4892, 1992
791992
Lysocins: bioengineered antimicrobials that deliver lysins across the outer membrane of Gram-negative bacteria
RD Heselpoth, CW Euler, R Schuch, VA Fischetti
Antimicrobial Agents and Chemotherapy 63 (6), 10.1128/aac. 00342-19, 2019
782019
nadA and nadB of Shigella flexneri 5a are antivirulence loci responsible for the synthesis of quinolinate, a small molecule inhibitor of Shigella pathogenicity
AL Prunier, R Schuch, RE Fernandez, KL Mumy, H Kohler, BA McCormick, ...
Microbiology 153 (7), 2363-2372, 2007
752007
The system can't perform the operation now. Try again later.
Articles 1–20